Nutritional Status of Cerebral Palsy Patients in Turkey

This is a single visit, non-interventional, cross sectional study about risk factors, etiology, nutritional status and feeding methods in CP patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Nutritional Status

Age range

1 year–19 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Adana Numune Training and Research Hospital, Adana, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subject is greater than/equal to 12 months and less than 19 years of age.
Subject is diagnosed with cerebral palsy (CP) by a physician.

Exclusion criteria

Subject presents with genopathies, cardiopathies, hypothyroidism or any pathology not related to CP.
Subject is diagnosed with CP of postnatal origin.
Subject has other concomitant diagnoses.

Treatment and study plan

Primary outcomes

prevalence of malnutrition

Time frame: at enrollment

physician assessment

Secondary outcomes

etiology of CP

Time frame: at enrollment

physician assessment/medical record
correlation between type of CP and nutritional status

Time frame: at enrollment

Sponsors and collaborators

Lead sponsor

Abbott Nutrition

Industry

Registry information

Official study title

A Prospective, Cross Sectional Study to Evaluate the Etiology and Nutritional Status of Cerebral Palsy Patients in Turkey

Important dates

Study start: 2015
Primary completion: 2016
Study completion: 2016
First posted: Oct 28, 2015
Registry last updated: Aug 1, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed